197 related articles for article (PubMed ID: 1813880)
1. [Late results of the treatment of advanced Hodgkin's disease by the MOPP/COPP programs (chlormethine or cyclophosphamide, vincristine, procarbazine and prednisone)].
Błasińska-Morawiec M; Płuzańska A; Krykowski E; Robak T; Mrówka I
Pol Arch Med Wewn; 1991 Oct; 86(4):274-80. PubMed ID: 1813880
[TBL] [Abstract][Full Text] [Related]
2. [Chemotherapy of advanced lymphogranulomatosis. Results of MOPP/COPP treatment at the West German Tumor Center, Essen].
Höffken K; Ippisch A; Pfeiffer R; Becher R; Seeber S; Schmidt CG
Dtsch Med Wochenschr; 1985 Apr; 110(16):618-23. PubMed ID: 3838719
[TBL] [Abstract][Full Text] [Related]
3. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
Canellos GP
Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509
[TBL] [Abstract][Full Text] [Related]
4. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic value of the results of short-term polychemotherapy by the MOPP program of Hodgkin's disease stages III and IV].
Hansz J; Burchardt K; Komarnicki M; Trepińska E; Psuja P
Pol Arch Med Wewn; 1984 Dec; 72(6):293-8. PubMed ID: 6549512
[No Abstract] [Full Text] [Related]
6. Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial.
Longo DL; Glatstein E; Duffey PL; Young RC; Hubbard SM; Urba WJ; Wesley MN; Raubitschek A; Jaffe ES; Wiernik PH
J Clin Oncol; 1991 Jun; 9(6):906-17. PubMed ID: 2033427
[TBL] [Abstract][Full Text] [Related]
7. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.
Pfreundschuh MG; Schoppe WD; Fuchs R; Pflüger KH; Loeffler M; Diehl V
Cancer Treat Rep; 1987 Dec; 71(12):1203-7. PubMed ID: 2446751
[TBL] [Abstract][Full Text] [Related]
8. Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatment.
Longo DL; Russo A; Duffey PL; Hubbard SM; Glatstein E; Hill JB; Jaffe ES; Young RC; DeVita VT
J Clin Oncol; 1991 Feb; 9(2):227-35. PubMed ID: 1988570
[TBL] [Abstract][Full Text] [Related]
9. BCVPP chemotherapy for advanced Hodgkin's disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Results of the Eastern Cooperative Oncology Group study.
Bakemeier RF; Anderson JR; Costello W; Rosner G; Horton J; Glick JH; Hines JD; Berard CW; DeVita VT
Ann Intern Med; 1984 Oct; 101(4):447-56. PubMed ID: 6089632
[TBL] [Abstract][Full Text] [Related]
10. Randomized study for the treatment of advanced Hodgkin's disease: MOPP vs. LOPP.
Avilés A; Díaz-Maqueo JC; García EL; Torras V; López-Vancell D
Arch Invest Med (Mex); 1991; 22(1):45-50. PubMed ID: 1819976
[TBL] [Abstract][Full Text] [Related]
11. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M
Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060
[TBL] [Abstract][Full Text] [Related]
12. [CVP or C-MOPP combination chemotherapy in the treatment of advanced Hodgkin's disease and non-Hodgkin's lymphoma (intermediate grade of working formulation)].
Sampi K; Honda T; Hattori M
Rinsho Ketsueki; 1984 Feb; 25(2):164-8. PubMed ID: 6547984
[No Abstract] [Full Text] [Related]
13. Free-from-failure survival in Hodgkin's disease. Long-term analysis of 148 cases treated with a MOPP-modified protocol.
Silingardi V; Federico M; Frassoldati A; Barbieri F; Palomba G; Mauri C
Acta Haematol; 1989; 82(4):179-86. PubMed ID: 2511719
[TBL] [Abstract][Full Text] [Related]
14. Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group.
Connors JM; Klimo P; Adams G; Burns BF; Cooper I; Meyer RM; O'Reilly SE; Pater J; Quirt I; Sadura A; Shustik C; Skillings J; Sutcliffe S; Verma S; Yoshida S; Zee B
J Clin Oncol; 1997 Apr; 15(4):1638-45. PubMed ID: 9193364
[TBL] [Abstract][Full Text] [Related]
15. Treatment of advanced Hodgkin's disease with modified MOPP regimens. A long-term observation.
Koza I; Bohunický L; Svancárová L; Mardiak J; Gyárfás J; Cerný V
Neoplasma; 1989; 36(6):709-18. PubMed ID: 2615874
[TBL] [Abstract][Full Text] [Related]
16. BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.
Diehl V; Franklin J; Hasenclever D; Tesch H; Pfreundschuh M; Lathan B; Paulus U; Sieber M; Rueffer JU; Sextro M; Engert A; Wolf J; Hermann R; Holmer L; Stappert-Jahn U; Winnerlein-Trump E; Wulf G; Krause S; Glunz A; von Kalle K; Bischoff H; Haedicke C; Duehmke E; Georgii A; Loeffler M
J Clin Oncol; 1998 Dec; 16(12):3810-21. PubMed ID: 9850026
[TBL] [Abstract][Full Text] [Related]
17. Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPP.
Longo DL; Duffey PL; DeVita VT; Wiernik PH; Hubbard SM; Phares JC; Bastian AW; Jaffe ES; Young RC
J Clin Oncol; 1991 Aug; 9(8):1409-20. PubMed ID: 1712836
[TBL] [Abstract][Full Text] [Related]
18. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
[TBL] [Abstract][Full Text] [Related]
19. Mopp chemotherapy in the treatment of stage IV Hodgkin's disease.
Fiacchini M; Lauria F; Mazza P; Cantore M; Gherlinzoni F; Tura S
Haematologica; 1985; 70(2):148-54. PubMed ID: 3924778
[No Abstract] [Full Text] [Related]
20. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.
Diehl V; Franklin J; Pfreundschuh M; Lathan B; Paulus U; Hasenclever D; Tesch H; Herrmann R; Dörken B; Müller-Hermelink HK; Dühmke E; Loeffler M;
N Engl J Med; 2003 Jun; 348(24):2386-95. PubMed ID: 12802024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]